Literature DB >> 464026

Hypoxia and incorporation of 3H-thymidine by cells of the rat pulmonary arteries and alveolar wall.

B Meyrick, L Reid.   

Abstract

In the pulmonary arterial circulation hypoxia produces increase in thickness of the medial muscle coat as well as of the adventitia; in addition muscle appears in smaller arteries than is normal and the number of small arteries that fill on Micropaque-gelatin injection is reduced. To assess the role of hyperplasia in these changes, the uptake of 3H-thymidine by the cells of the pulmonary arterial wall has been studied in rats exposed to hypobaric hypoxia (exposure to 380 torr) after 1, 3, 5, 7, 10, and 14 days. Using autoradiographs of 1-micron sections, the glutaraldehyde-distended intrapulmonary hilar muscular artery, the peripheral, intraacinar arteries less than 100 micron in external diameter, and the alveolar wall had different patterns of uptake. In the hilar pulmonary artery, after 24 hours of exposure, the labeling index for adventitial fibroblasts is increased eightfold over the control value, and for endothelial cells, threefold, while for medial smooth muscle cells, there is a gradual and small increase to Day 14. Newly muscularized intraacinar arteries are first apparent at Day 3, when they comprise 40% of the intraacinar arteries, increasing to 80% at Day 7. No decrease in density of arteries is found. Uptake of 3H-thymidine by new muscle cells is not apparent until Day 5 when labeling is maximum. The endothelial cells of the newly muscularized arteries show an increased labeling index only at Days 7 and 10. The veins and normally muscular arteries do not show these changes. In the alveolar walls, the concentration of labeled cells is significantly above the control value at Days 3, 5, and 7 and significantly below, at Day 14. At this level, the interstitial, epithelial, and endothelial cells contribute to the increase.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 464026      PMCID: PMC2042349     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Ultrastructural features of the distended pulmonary arteries of the normal rat.

Authors:  B Meyrick; L Reid
Journal:  Anat Rec       Date:  1979-01

2.  THE TERMINAL PORTION OF THE PULMONARY ARTERIAL TREE IN PEOPLE NATIVE TO HIGH ALTITUDES.

Authors:  J ARIAS-STELLA; M SALDANA
Journal:  Circulation       Date:  1963-11       Impact factor: 29.690

3.  APPARATUS FOR EXPOSING ANIMALS TO REDUCED ATMOSPHERIC PRESSURE FOR LONG PERIODS.

Authors:  B M WRIGHT
Journal:  Br J Haematol       Date:  1964-01       Impact factor: 6.998

4.  Hypoxemia and pulmonary hypertension. A study of the pulmonary vasculature.

Authors:  R L NAEYE
Journal:  Arch Pathol       Date:  1961-04

5.  Development of pulmonary arterial changes in rats fed Crotalaria spectabilis.

Authors:  B Meyrick; L Reid
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

6.  The pulmonary circulation in chronic bronchitis and emphysema.

Authors:  D M Shelton; E Keal; L Reid
Journal:  Chest       Date:  1977-02       Impact factor: 9.410

7.  Ventricular weight in cardiac hypertrophy.

Authors:  R M FULTON; E C HUTCHINSON; A M JONES
Journal:  Br Heart J       Date:  1952-07

8.  The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study.

Authors:  B Meyrick; L Reid
Journal:  Lab Invest       Date:  1978-02       Impact factor: 5.662

9.  Changes in the pulmonary arteries of the rat during recovery from hypoxia-induced pulmonary hypertension.

Authors:  A Hislop; L Reid
Journal:  Br J Exp Pathol       Date:  1977-12

10.  New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.

Authors:  A Hislop; L Reid
Journal:  Br J Exp Pathol       Date:  1976-10
View more
  51 in total

Review 1.  Cellular responses to hypoxia in the pulmonary circulation.

Authors:  S O Brij; A J Peacock
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

2.  Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.

Authors:  Rubin M Tuder; Laura A Davis; Brian B Graham
Journal:  Am J Respir Crit Care Med       Date:  2011-11-10       Impact factor: 21.405

Review 3.  One hundred years of research in the pathogenesis of pulmonary hypertension.

Authors:  Ari Zaiman; Iwona Fijalkowska; Paul M Hassoun; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11       Impact factor: 6.914

Review 4.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

5.  Cell signalling in pulmonary vascular cells: do not shoot the messenger!

Authors:  P H Scott; A J Peacock
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

Review 6.  Multilineage stem cells in the adult: a perivascular legacy?

Authors:  Mihaela Crisan; Mirko Corselli; Chien-Wen Chen; Bruno Péault
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

7.  Inhalation of chrysotile asbestos induces rapid cellular proliferation in small pulmonary vessels of mice and rats.

Authors:  P D McGavran; L B Moore; A R Brody
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

8.  The effect of isoproterenol on the development and recovery of hypoxic pulmonary hypertension. A structural and hemodynamic study.

Authors:  R Fried; L M Reid
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

Review 9.  The ultrastructure of human fibrosing alveolitis.

Authors:  J J Coalson
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

10.  Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α.

Authors:  Aftab Ahmad; Shama Ahmad; Kenneth C Malcolm; Stacy M Miller; Tara Hendry-Hofer; Jerome B Schaack; Carl W White
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.